Soin Neuroscience secures IRB approval to commence clinical case series studying spinal cord stimulator alogrithms

Biotech company based in Dayton,OH has received IRB approval to initiate a Clinical case series studying spinal cord stimulator alogrithms in patients afflicted with back pain.

Dr. Amol Soin who is a pain management physician and CEO of Soin Neuroscience set to conduct the study in Dayton stated “I look forward to using Nuvectra’s Algovita, and its powerful spinal cord stimulator system to treat patients with back pain. We will be trialing waveforms that are unique to Nuvectra’s system. This is a small study that I hope will allow us to run additional larger studies. I think we can help a lot of people with back pain.”